Impact of mucosal healing on long‐term outcomes in ulcerative colitis treated with infliximab: a multicenter experience
Alimentary Pharmacology & Therapeutics2013Vol. 37(10), pp. 998–1004
Citations Over TimeTop 1% of 2013 papers
David Laharie, Jérôme Filippi, Xavier Roblin, Stéphane Nancey, Jean‐Baptiste Chevaux, Xavier Hébuterne, Bernard Flourié, Maylis Capdepont, Laurent Peyrin‐Biroulet
Abstract
Patients with refractory UC who achieved mucosal healing after IFX initiation had better long-term outcomes, with significantly less colectomy and less IFX failure.
Related Papers
- → Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006(2007)116 cited
- → Utilization and surgical procedures following Colectomy in patients with Ulcerative Colitis(2009)
- → 21 NATURAL HISTORY OF COLECTOMY AMONG HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS IN THE CONTEMPORARY ERA OF BIOLOGICS(2020)
- → Predictors of the efficacy of infliximab in patients with ulcerative colitis(2022)